Lidocaine/Sodium Chloride Injectable Recalled Due to Sterility Concerns
Specialty Medicine Compounding Pharmacy is recalling Lidocaine/Sodium Chloride injectable products because sterility cannot be assured after a related product was found non-sterile.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in injectable products, which poses a significant risk of infection or serious injury.
Plain-English summary
Specialty Medicine Compounding Pharmacy is recalling all unexpired sterile compounded human and veterinary products, specifically Lidocaine/Sodium Chloride 0.4%/18% Injectable. The recall is being conducted because these products were compounded in the same environment and under the same practices as another product that was found to be non-sterile. Consequently, the sterility of the recalled products cannot be assured.
The affected products were manufactured and distributed between July 1, 2013, and October 19, 2013. Specific lot numbers include t08142013@39, t09052013@40, t09122013@3, and t09122013@25. The products were distributed to hospitals, clinics, physicians, and patients in the Michigan area only.
Patients and healthcare providers should stop using the recalled products and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- LIDOCAINE/SODIUM CHL* 0.4 %/18 % INJECTABLE; all sizes, Rx only, Specialty Medicine Compounding Pharmacy, 350 S Lafayette, South Lyon, MI 48178
- Manufacturer
- Specialty Medicine Compounding Pharmacy
- Category
- Drug — Injectable
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- All unexpired lots
- manufactured and distributed between 07/01/2013 and 10/19/2013
- including Lot #s: t08142013@39
- t09052013@40
- t09122013@3
- t09122013@25
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 51 recalled by Specialty Medicine Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 51 products in this recall →Related recalls
Same manufacturer · Specialty Medicine Compounding Pharmacy
See all →- Severe
- SevereSpecialty Medicine Compounding Pharmacy Recalls Combo Eye Gel Due to Sterility Concerns
FDA (Drugs) · 2014-01-22
- SevereHyaluronidase Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2014-01-22
- SeverePhenol Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2014-01-22
- SevereCyanocobalamin Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-01-22
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereLiberty Drug Recalls Lidocaine Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-09-02
- SeverePharmedium Recalls Lidocaine HCl Injection Due to Sterility Concerns
FDA (Drugs) · 2018-02-28
- SevereMitomycin Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2015-09-23
- SevereRed Mountain Compounding Pharmacy Recalls Lidocaine HCL Injection Due to Sterility Concerns
FDA (Drugs) · 2019-11-13
- SevereSodium Chloride Recall Due to Sterility Concerns
FDA (Drugs) · 2013-07-10
- SevereMitomycin Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23